Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Various types of meropenem administration in patients with ventilator-associated pneumonia and augmented renal clearance
IRCT20130917014693N12Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of meropenem in ventilator-associated pneumonia (VAP), sponsored by Shahid Beheshti University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
meropenem
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20130917014693N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130917014693N12.